Stay updated on KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial
Sign up to get notified when there's something new on the KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial page.

Latest updates to the KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a Locations section with Western Australia as a new site. Removed the Western Australia Locations header and the HHS Vulnerability Disclosure footer link; the page revision updated to v3.3.3.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed on the page.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the government funding/operating status notice from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedNo significant changes detected in the page content; core study details and criteria remain as previously displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds a government-funding-related status message and directs users to official sources for current operations.SummaryDifference4%

- Check98 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0 with removals of several MedlinePlus drug-safety topics and related MeSH terms; the page’s content scope appears to be narrowed rather than expanded.SummaryDifference1.0%

Stay in the know with updates to KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial page.